Skip to main content
Log in

In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: The purpose of this study was to assess the immunocytochemical status of bone marrow aspirates from patients with clinically isolated hepatic metastases to test the hypothesis that such findings would allow improved patient selection for liver-directed treatment. METHODS: All patients had biopsy-proven or presumed colorectal cancer metastatic to the liver and were scheduled for an operative procedure for hepatic resection or for hepatic artery catheter and chemotherapy pump implant. Immunocytochemical analysis of bone marrow aspirate smears was performed with a panel of monoclonal antibodies directed toward cytokeratins, Lewis Y antigen and A-33 colorectal epitopes. RESULTS: Data from 80 patients indicated that bone marrow reactivity was present in 9.5 percent of those with resectable hepatic metastases and in 34 percent of those not resected (P=0.03). No single monoclonal antibody or combination produced better discrimination. CONCLUSIONS: Presence or absence of presumed occult colorectal cancer cells in the bone marrow of patients with isolated hepatic metastases is biologically interesting, but not useful in selecting or altering patient management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ellis G, Ferguson M, Yamanaka E, Livingston RB, Gown AM. Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer 1989;63:2509–14.

    PubMed  Google Scholar 

  2. Dearnaley DP, Sloane JP, Ormerod MG,et al. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigens. Br J Cancer 1981;44:85–90.

    PubMed  Google Scholar 

  3. Ceci G, Franciosi V, Nizzoli R,et al. The value of bone marrow biopsy in breast cancer at time of diagnosis. A prospective study. Cancer 1988;61:96–8.

    PubMed  Google Scholar 

  4. Redding WH, Coombes RC, Monaghan P,et al. Detection of micrometastases in patients with primary breast cancer. Lancet 1983;2:1271–4.

    Article  PubMed  Google Scholar 

  5. Cote RJ, Rosen PP, Hakes TB,et al. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 1988;12:333–40.

    PubMed  Google Scholar 

  6. Coombes RC, Berger U, Mansi J,et al. Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer. Natl Cancer Inst Monogr 1986;1:51–3.

    Google Scholar 

  7. Porro G, Menard S, Tagliabue E,et al. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988;61:2407–11.

    PubMed  Google Scholar 

  8. Singletary SE, Lille L, Tucker SL, Spitzer G. Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 1991;47:32–6.

    PubMed  Google Scholar 

  9. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer, and prognosis. Am J Clin Pathol 1988;90:1–6.

    PubMed  Google Scholar 

  10. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219–26.

    PubMed  Google Scholar 

  11. Hay FG, Ford A, Leonard RC. Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer. Int J Cancer Suppl 1988;2:8–10.

    PubMed  Google Scholar 

  12. Canon JL, Humblet Y, Lebacq-Verheyden AM,et al. Utilization of three monoclonal antibodies to monitor bone marrow involvement by small cell lung cancer. Proc Am Assoc Cancer Res 1987;28:216.

    Google Scholar 

  13. Schneider BM, Schlimok G, Riethmuller G, Witte J. Bone marrow micrometastases in colon cancer. Fortschr Med 1989;107:59–63.

    PubMed  Google Scholar 

  14. Mansi JL, Berger U, Wilson P, Shearer R, Coombes RC. Detection of tumor cells in bone marrow of patients with prostatic cancer by immunocytochemical techniques. J Urol 1988;139:545–8.

    PubMed  Google Scholar 

  15. Dantas ME, Brown JP, Thomas MR, Robinson WA, Glode LM. Detection of melanoma cells in bone marrow using monoclonal antibodies. A comparison of flourescence activated cell sorting (FACS) and conventional immunoflourescence (IF). Cancer 1983;52:949–53.

    PubMed  Google Scholar 

  16. Fong Y, Cohen AM, Fortner JG,et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938–46.

    PubMed  Google Scholar 

  17. Welt S, Divgi CR, Real FX, Yeh SD,et al. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. J Clin Oncol 1990;8:1894–906.

    PubMed  Google Scholar 

  18. Blaszczyk-Thurin M, Thurin J, Hindsgaul O, Karlsson KA, Steplewski Z, Koprowski H. Y and blood group B type 2 glycolipid antigens accumulate in human gastric carcinoma cell lines as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR. J Biol Chem 1987;262:372–9.

    PubMed  Google Scholar 

  19. Garin-Chesa P, Rettig WJ, Melamed MR. Expression of cytokeratins in normal and neoplastic colonic epithelial cells: implications for cellular differentiation and carcinogenesis. Am J Surg Pathol 1986;10:829–35.

    PubMed  Google Scholar 

  20. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell 1982;31:11–24.

    Article  PubMed  Google Scholar 

  21. Cordell JL, Fauni B, Erber WN,et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219–29.

    PubMed  Google Scholar 

  22. Schlimok G, Funke I, Holzmann B,et al. Micrometastatic cancer cells in bone marrow:in vitro detection with anticytokeratin andin vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci U S A 1987;84:8672–6.

    PubMed  Google Scholar 

  23. Schlimok G, Funke I, Bock B, Schwerberer B, Witte J, Riethmuller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 1990;8:831–7.

    PubMed  Google Scholar 

  24. O'Sullivan GC, Collins JK, O'Brien FO,et al. Micrometastases in bone marrow of patients undergoing “curative” surgery for gastrointestinal cancer. Gastroenterology 1995;109:1535–40.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by the Ludwig Institute.

About this article

Cite this article

Cohen, A.M., Garin-Chesa, P., Hanson, M. et al. In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases. Dis Colon Rectum 41, 1112–1115 (1998). https://doi.org/10.1007/BF02239432

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02239432

Key words

Navigation